Alginate lyase — Drug Target

All drugs that target Alginate lyase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Microbiome modulator

Phase 3 pipeline (1)

• ALGRX 3268 · AlgoRx Pharmaceuticals · Microbiome modulator · Gastroenterology / Immunology
  ALGRX 3268 is a selective inhibitor of alginate lyase that modulates the gut microbiome by targeting bacterial polysaccharide degradation.